Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

37.73
BATS BZX Real-Time Price
As of 1:46pm ET
 +0.055 / +0.15%
Today’s Change
37.36
Today|||52-Week Range
45.58
-5.17%
Year-to-Date
Has GlaxoSmithKline Finally Turned the Corner?
7:12am / MotleyFool.com - Paid Partner Content
Here's the Best Dividend Stock in Big Pharma
Dec 01 / MotleyFool.com - Paid Partner Content
Robust Pipeline Supports 5.5% Dividend Yield
Dec 05 / GuruFocus News - Paid Partner Content
10 Undervalued High-Yield Dividend Stocks Worth Buying Today
Nov 30 / TheStreet.com - Paid Partner Content
How to Buy GlaxoSmithKline at a 15% Discount
Dec 02 / TheStreet.com - Paid Partner Content
Merck: Keytruda's Priority Review for New Cancer Indication
Nov 29 / Zacks.com - Paid Partner Content
Merck's Keytruda Gets Priority Review for Hodgkin Lymphoma
Dec 02 / Zacks.com - Paid Partner Content
Glaxo (GSK) Files Regulatory Application for Shingrix in EU
Nov 28 / Zacks.com - Paid Partner Content
Jeff Auxier Curbs Multiple Positions in 3rd Quarter
Dec 01 / GuruFocus News - Paid Partner Content
Glaxo Nucala Favorable in Rare Vasculitis Disease Study
Nov 24 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close37.67
Today’s open37.63
Day’s range37.48 - 37.79
Volume198,953
Average volume (3 months)3,254,213
Market cap$91.8B
Dividend yield5.53%
Data as of 1:46pm ET, 12/06/2016

Growth & Valuation

Earnings growth (last year)+181.82%
Earnings growth (this year)+10.59%
Earnings growth (next 5 years)+13.26%
Revenue growth (last year)-3.66%
P/E ratio337.2
Price/Sales2.70
Price/Book12.09

Competitors

 Today’s
change
Today’s
% change
BMYBristol-Myers Squibb+0.20+0.35%
CELGCelgene+0.65+0.56%
ABBVAbbVie+0.75+1.23%
SNYSanofi-0.41-1.00%
Data as of 1:46pm ET, 12/06/2016

Financials

Next reporting dateFebruary 8, 2017
EPS forecast (this quarter)$0.57
Annual revenue (last year)$36.5B
Annual profit (last year)$12.8B
Net profit margin35.20%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Andrew Philip Witty
Chief Financial Officer &
Executive Director
Simon Dingemans
Corporate headquarters
Brentford, Greater London

Forecasts


Search for Jobs